CTA Specialist's Mission:
The mission of the Clinical Trial Agreements Specialist is to facilitate and enhance the timely execution of quality clinical research at UT Southwestern Medical Center by providing services to faculty and staff in connection with industry-sponsored and industry-supported clinical trials. The CTA Specialist provides both pharmaceutical (investigational drug services) and non-clinical (contractual) services to investigators working collaboratively with pharmaceutical and biotechnical companies.
|
CTA Services:
|
- Contract Preparation
-
- Clinical Trial Agreements
- Amendments to Agreements
- Confidentiality Agreements
- Investigational Drug Services (IDS)
|
The CTA Specialist works with pharmaceutical and biotechnical companies who are willing to provide protocols, drugs/devices and/or funding to UT Southwestern investigators to further advance clinical research by negotiating and processing contracts in a timely manner and in accordance with State law, UT System Regents’ Rules and UT Southwestern policies. The CTA Specialist also assists in postaward administrative issues such as receiving and acknowledging checks for industry-sponsored clinical trial agreements.
Investigational Drug Services are provided by pharmacists and pharmacy technicians who assist principal investigators with the pharmaceutical aspects of clinical trials. The IDS is available in Aston Ambulatory Care Center, Children's Medical Center of Dallas, Parkland Memorial Hospital, St. Paul University Hospital and Zale Lipshy University Hospital. These services are available to clinical investigators in all areas of research involving medications or devices. When appropriate, the IDS can counsel subjects about their medications, aid in promoting protocol adherence and support data collection or protocol development. The IDS maintains a complete copy of the protocol for each study with which it is involved and is available for consultation between the hours of 8:00 am and 5:00 pm M-F.
Please contact us promptly so that we may provide assistance with clinical trials. We also welcome comments and feedback to enable us to better serve the research community. |